Macro Group Pharmaceuticals (Macro Capital) S.A.E

CASE:MCRO Stock Report

Market Cap: ج.م1.1b

Macro Group Pharmaceuticals (Macro Capital)E Past Earnings Performance

Past criteria checks 0/6

Macro Group Pharmaceuticals (Macro Capital)E's earnings have been declining at an average annual rate of -43.1%, while the Personal Products industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 12.2% per year.

Key information

-43.1%

Earnings growth rate

-43.1%

EPS growth rate

Personal Products Industry Growth8.7%
Revenue growth rate12.2%
Return on equity-289.0%
Net Margin-51.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Macro Group Pharmaceuticals (Macro Capital)E makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CASE:MCRO Revenue, expenses and earnings (EGP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23526-2734510
30 Sep 237991423550
31 Mar 237501533410
31 Dec 227301743170
30 Sep 226971713020
30 Jun 226661792800
31 Mar 226111672620
31 Dec 215941482570
30 Sep 215441432290
31 Dec 204311351590

Quality Earnings: MCRO is currently unprofitable.

Growing Profit Margin: MCRO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MCRO's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MCRO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MCRO is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (14.4%).


Return on Equity

High ROE: MCRO has a negative Return on Equity (-289.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.